Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?
about
Diversity of actions of GnRHs mediated by ligand-induced selective signalingGonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling.Receptor-mediated tumor targeting based on peptide hormones.Hybrid curcumin compounds: a new strategy for cancer treatment.GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.Synthesis, characterization and systematic comparison of FITC-labelled GnRH-I, -II and -III analogues on various tumour cells.Gonadotropin‑releasing hormone inhibits the proliferation and motility of nasopharyngeal carcinoma cells.Investigation of structure-activity relationships of synthetic anti-gonadotropin releasing hormone vaccine candidates.Silencing of the GnRH type 1 receptor blocks the antiproliferative effect of the GnRH agonist, leuprolide, on the androgen-independent prostate cancer cell line DU145.Involvement of NF-kappaB subunit p65 and retinoic acid receptors, RARalpha and RXRalpha, in transcriptional regulation of the human GnRH II gene.Determination of acidity constants and ionic mobilities of polyprotic peptide hormones by CZE.On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.
P2860
Q30439870-6BB04ADB-4A01-4B90-AEC1-62912A688231Q33642701-C81F5C62-B465-477B-B745-1852D97626EFQ37641368-90A7F479-417C-401A-B1C0-0625ED60F4D3Q38290418-B9BF1A22-C7F6-4CE9-B425-3B54E4EF93B3Q38682630-D2B3F854-5C9F-4C1E-803E-AFB696B55805Q38756598-9F8AE949-B03F-480C-96DE-3202F94B8C6BQ38855783-B0E70C47-6D93-40E4-A8B1-573B1EEF5503Q38895112-21361916-1EA9-4E06-9573-D0D11AD6D9F4Q39494573-ED45226B-5BFD-40A7-BC1E-8619C8B10865Q40142565-344E2807-0B53-4750-81B4-AB7F067DCF93Q45904099-36BA7D03-0F3F-4CB2-85B5-1FC4470B5320Q55054276-E733FC2D-9F28-4B46-9125-EADAD59E4FF3
P2860
Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Gonadotropin-releasing hormone ...... RH analogs in cancer patients?
@ast
Gonadotropin-releasing hormone ...... RH analogs in cancer patients?
@en
type
label
Gonadotropin-releasing hormone ...... RH analogs in cancer patients?
@ast
Gonadotropin-releasing hormone ...... RH analogs in cancer patients?
@en
prefLabel
Gonadotropin-releasing hormone ...... RH analogs in cancer patients?
@ast
Gonadotropin-releasing hormone ...... RH analogs in cancer patients?
@en
P50
P1476
Gonadotropin-releasing hormone ...... RH analogs in cancer patients?
@en
P2093
M Montagnani Marelli
P304
P356
10.2174/156800906776842966
P577
2006-05-01T00:00:00Z